Sensus Healthcare director buys 20.6K shares

Sensus Healthcare, Inc. (SRTS) director Eric Sachetta reported open-market purchases of the company’s common stock.

Rhea-AI Filing Summary

Sensus Healthcare, Inc. (SRTS) director Eric Sachetta reported open-market purchases of the company’s common stock. On August 27, 2026, he purchased 10,925 shares at $3.181 per share, and on August 26, 2026 he purchased 9,708 shares at $3.289 per share, for a total of 20,633 shares acquired directly. The filing also reports an indirect holding of 2,093 shares held through his spouse.

Insider Trade Summary

Net Buyer: 20,633 shares

Net Buy 3 txns

Insider Sachetta Eric

Role Director

Bought 20,633 shs ($67K)

Type	Security	Shares	Price	Value
Purchase	Common Stock	10,925	$3.181	$35K
Purchase	Common Stock	9,708	$3.289	$32K
holding	Common Stock	--	--	--

Holdings After Transaction: Common Stock — 229,943 shares (Direct); Common Stock — 2,093 shares (Indirect, Spouse)

Key Figures

Shares purchased (2026-08-27): 10,925 shares of Common Stock Purchase price (2026-08-27): $3.181 per share Shares purchased (2026-08-26): 9,708 shares of Common Stock +3 more

6 metrics

Shares purchased (2026-08-27) 10,925 shares of Common Stock Open-market or private purchase on August 27, 2026

Purchase price (2026-08-27) $3.181 per share Price paid for 10,925 shares on August 27, 2026

Shares purchased (2026-08-26) 9,708 shares of Common Stock Open-market or private purchase on August 26, 2026

Purchase price (2026-08-26) $3.289 per share Price paid for 9,708 shares on August 26, 2026

Total shares purchased 20,633 shares of Common Stock Sum of reported purchases on August 26 and 27, 2026

Indirect holdings (spouse) 2,093 shares of Common Stock Indirect ownership through spouse after transaction

Key Terms

transaction code, open market or private transaction, indirect ownership

3 terms

transaction code regulatory

"The filing lists a transaction code "P" for the purchases"

open market or private transaction financial

"The transaction code description is "Purchase in open market or private transaction""

indirect ownership financial

"One entry shows indirect ownership classified as "Spouse""

FAQ

What insider transactions did SRTS director Eric Sachetta report?

Eric Sachetta reported two open-market purchases of Sensus Healthcare common stock, totaling 20,633 shares on August 26 and 27, 2026, plus an indirect holding of 2,093 shares held through his spouse.

How many SRTS shares did Eric Sachetta buy on August 27, 2026?

On August 27, 2026, Eric Sachetta purchased 10,925 shares of Sensus Healthcare common stock at a price of $3.181 per share in an open-market or private transaction.

How many SRTS shares did Eric Sachetta buy on August 26, 2026 and at what price?

On August 26, 2026, Eric Sachetta purchased 9,708 shares of Sensus Healthcare common stock at a price of $3.289 per share in an open-market or private transaction.

What is the total number of SRTS shares Eric Sachetta purchased in this Form 4?

Across the reported transactions, Eric Sachetta purchased a total of 20,633 shares of Sensus Healthcare common stock, combining 10,925 shares bought on August 27, 2026 and 9,708 shares bought on August 26, 2026.

Does Eric Sachetta have any indirect ownership of SRTS shares?

Yes. The Form 4 reports an indirect ownership position of 2,093 shares of Sensus Healthcare common stock held through his spouse, classified as indirect (I) ownership.

Were Eric Sachetta’s SRTS trades under a Rule 10b5-1 trading plan?

The filing’s Rule 10b5-1 checkbox is marked false, indicating the reported transactions were not affirmed as being made pursuant to a Rule 10b5-1 trading plan.

AI-generated analysis. How Rhea-AI works. Not financial advice.

Form 4 Insider Transactions: What Each Field Means →

See more from StockTitan in Google Search and AI answers. Adds StockTitan as a preferred source · opens Google

Add on Google Not now

Available on EDGAR 08/28/2026 - 02:29 PM Accepted by SEC EDGAR 08/28/2026 - 02:29 PM Learn about SEC filing dates

SEC Form 4

FORM 4

UNITED STATES SECURITIES AND EXCHANGE COMMISSION
Washington, D.C. 20549

STATEMENT OF CHANGES IN BENEFICIAL OWNERSHIP

Filed pursuant to Section 16(a) of the Securities Exchange Act of 1934
or Section 30(h) of the Investment Company Act of 1940

OMB APPROVAL

OMB Number:			3235-0287
Estimated average burden
hours per response:			0.5

Check this box if no longer subject to Section 16. Form 4 or Form 5 obligations may continue. See Instruction 1(b).

Check this box to indicate that a transaction was made pursuant to a contract, instruction or written plan for the purchase or sale of equity securities of the issuer that is intended to satisfy the affirmative defense conditions of Rule 10b5-1(c). See Instruction 10.

1. Name and Address of Reporting Person^*

Sachetta Eric

(Last) (First) (Middle)

851 BROKEN SOUND PARKWAY NW #215

(Street)

BOCA RATON FLORIDA 33487

(City) (State) (Zip)

UNITED STATES

(Country)

2. Issuer Name and Ticker or Trading Symbol
Sensus Healthcare, Inc. [ SRTS ]

5. Relationship of Reporting Person(s) to Issuer
(Check all applicable)

X	Director		10% Owner
	Officer (give title below)		Other (specify below)

2a. Foreign Trading Symbol

3. Date of Earliest Transaction (Month/Day/Year)
08/26/2026

6. Individual or Joint/Group Filing (Check Applicable Line)

X	Form filed by One Reporting Person
	Form filed by More than One Reporting Person

4. If Amendment, Date of Original Filed (Month/Day/Year)

Table I - Non-Derivative Securities Acquired, Disposed of, or Beneficially Owned
1. Title of Security (Instr. 3)	2. Transaction Date (Month/Day/Year)	2A. Deemed Execution Date, if any (Month/Day/Year)	3. Transaction Code (Instr. 8)		4. Securities Acquired (A) or Disposed Of (D) (Instr. 3, 4 and 5)			5. Amount of Securities Beneficially Owned Following Reported Transaction(s) (Instr. 3 and 4)	6. Ownership Form: Direct (D) or Indirect (I) (Instr. 4)	7. Nature of Indirect Beneficial Ownership (Instr. 4)
			Code	V	Amount	(A) or (D)	Price
Common Stock	08/26/2026		P		9,708	A	$3.289	219,018	D
Common Stock	08/27/2026		P		10,925	A	$3.181	229,943	D
Common Stock								2,093	I	Spouse

Table II - Derivative Securities Acquired, Disposed of, or Beneficially Owned (e.g., puts, calls, warrants, options, convertible securities)
1. Title of Derivative Security (Instr. 3)	2. Conversion or Exercise Price of Derivative Security	3. Transaction Date (Month/Day/Year)	3A. Deemed Execution Date, if any (Month/Day/Year)	4. Transaction Code (Instr. 8)		5. Number of Derivative Securities Acquired (A) or Disposed of (D) (Instr. 3, 4 and 5)		6. Date Exercisable and Expiration Date (Month/Day/Year)		7. Title and Amount of Securities Underlying Derivative Security (Instr. 3 and 4)		8. Price of Derivative Security (Instr. 5)	9. Number of derivative Securities Beneficially Owned Following Reported Transaction(s) (Instr. 4)	10. Ownership Form: Direct (D) or Indirect (I) (Instr. 4)	11. Nature of Indirect Beneficial Ownership (Instr. 4)
				Code	V	(A)	(D)	Date Exercisable	Expiration Date	Title	Amount or Number of Shares

Explanation of Responses:

	/s/ Eric Sachetta	08/28/2026
	** Signature of Reporting Person	Date
Reminder: Report on a separate line for each class of securities beneficially owned directly or indirectly.
* If the form is filed by more than one reporting person, see Instruction 4 (b)(v).
** Intentional misstatements or omissions of facts constitute Federal Criminal Violations See 18 U.S.C. 1001 and 15 U.S.C. 78ff(a).
Note: File three copies of this Form, one of which must be manually signed. If space is insufficient, see Instruction 6 for procedure.
Persons who respond to the collection of information contained in this form are not required to respond unless the form displays a currently valid OMB Number.
* Form 4: SEC 1474 (03-26)